What is Bridgeway Diagnostics?
Bridgeway Diagnostics operates as a physician-owned entity, providing a comprehensive suite of diagnostic imaging services. Their offerings include advanced technologies such as low-dose CT, X-Ray, Ultrasound, DXA, and digital mammography. Notably, Bridgeway Diagnostics is recognized as the region's first outpatient facility to offer radiation dose reduction CT and low-dose 3D breast tomography. The practice serves a broad patient base, accommodating individuals with specific needs like metal implants or those requiring non-contrast MRI, thereby ensuring accessibility and high-quality imaging. With established locations in Auburn, Columbus, and Phenix City, the company is dedicated to delivering superior patient care and facilitating early disease detection.
How much funding has Bridgeway Diagnostics raised?
Bridgeway Diagnostics has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Bridgeway Diagnostics
PPP
Public-Private Partnership
What's next for Bridgeway Diagnostics?
The substantial late-stage capital infusion into Bridgeway Diagnostics signals a strategic push for scaling operations, potentially through geographic expansion, acquisition of new technologies, or enhancement of existing service lines. This financing will likely enable the company to solidify its market leadership, invest in further research and development for advanced imaging techniques, and potentially broaden its network of affiliated physicians and facilities. The focus on strategic investment indicates a clear path towards strengthening its competitive advantage and increasing its market share in the diagnostic radiology landscape.
See full Bridgeway Diagnostics company page
